Certified by Founder Lodge 
                                        
                                        Droia Ventures
 
                                                 Belgium  -  Meise, Belgium 
                                             INVESTOR 
                                            
                                                                                    1 Disclosed Funding Rounds $60,000,000
                                            5 Participating Investments
- 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            Droia Ventures is a specialist investor, dedicated to making an impact and save patient lives. Droia invests in novel science and innovative approaches to bring promising drug candidates to p
                                        
                                        
                                        
                                                                                
                                        
                                        
                                        
                                        
                                                                                
                                        | Company | Date | Round | Raised | 
|---|---|---|---|
   Volastra Therapeutics | 
                                                            March, 08 ,2023 | Series A | $60,000,000 | 
   QurAlis | 
                                                            March, 10 ,2023 | Series B | $88,000,000 | 
   Actio Biosciences, Inc. | 
                                                            September, 15 ,2023 | Series A | $55,000,000 | 
   Judo Bio | 
                                                            October, 08 ,2024 | Seed | $100,000,000 | 
   Hillstar Bio | 
                                                            April, 02 ,2025 | Series A | Undisclosed Amount | 
                                                
  Volastra Therapeutics
  QurAlis
  Actio Biosciences, Inc.
  Judo Bio
  Hillstar Bio
Cherry Ventures
 
                                            
Blue Bear Capital
 
                                            
Slow Ventures
Climate Capital
Eniac Ventures
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)